- Home
- GITS vs ADIL Comparison
GITS vs ADIL Comparison
Compare GITS & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GITS | ADIL |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | South Korea | United States |
| Employees | 5 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 7.3M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | GITS | ADIL |
|---|---|---|
| Price | $2.75 | $4.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | 22.4K | ★ 58.2K |
| Earning Date | 05-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $0.13 |
| 52 Week High | $7.09 | $5.17 |
Technical Indicators
Market Signals| Indicator | GITS | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 66.05 | 67.83 |
| Support Level | $1.98 | $2.38 |
| Resistance Level | $2.84 | $5.17 |
| Average True Range (ATR) | 0.21 | 0.40 |
| MACD | 0.03 | 0.13 |
| Stochastic Oscillator | 86.25 | 71.78 |
Price Performance
Historical ComparisonAbout GITS Global Interactive Technologies Inc.
Global Interactive Technologies Inc is operating and developing Faning, a digital fan engagement platform focused on Korean entertainment and culture, including K-pop. Faning is designed to support online fan communities, user interaction, multilingual communication, and digital engagement experiences across mobile and web-based services. The platform evolved from the legacy Fantoo platform ecosystem. The Company's primary operational focus was the continued development, maintenance, and support of the Faning platform. The Company operates its business through its core Faning platform and strategy.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.